Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Ovarian Neoplasms D010051 10 associated lipids
Pain D010146 64 associated lipids
Contusions D003288 3 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Cattle Diseases D002418 24 associated lipids
Fatty Liver D005234 48 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Embolism D011655 5 associated lipids
Coronary Disease D003327 70 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypothyroidism D007037 32 associated lipids
Rhinitis D012220 10 associated lipids
Hypercapnia D006935 5 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Pain, Postoperative D010149 13 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Zaitsu M et al. Thromboxane synthesis is increased by upregulation of cytosolic phospholipase A2 and cyclooxygenase-2 in peripheral polymorphonuclear leukocytes during bacterial infection in childhood. 2003 Am. J. Hematol. pmid:12555215
Kirchheiner J et al. Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans. 2003 Br J Clin Pharmacol pmid:12534640
von Aulock S et al. Determination of the eicosanoid response to inflammatory stimuli in whole blood and its pharmacological modulation ex vivo. 2003 J. Immunol. Methods pmid:12799039
Cabrera DM et al. A thromboxane A(2) system in the Atlantic stingray, Dasyatis sabina. 2003 Gen. Comp. Endocrinol. pmid:12568793
Yregård L et al. Influence of local anaesthetics on inflammatory activity postburn. 2003 Burns pmid:12781610
Ersöz G et al. Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. 2003 Thromb. Res. pmid:14698654
Chen L et al. Cyclooxygenase inhibitor blocks rebound response after NO inhalation in an endotoxin model. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12485821
Zhuang HP et al. [Effect of aspirin combined with perindopril on prostacyclin, thromboxone A2, and norepinephrine in the blood of arteriosclerosis rabbit models and the cardiac function]. 2003 Hunan Yi Ke Da Xue Xue Bao pmid:12934393
Castellani S et al. Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure. 2003 J. Am. Coll. Cardiol. pmid:12849673
Pettus BJ et al. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. 2003 J. Biol. Chem. pmid:12855693
Shimada N et al. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients. 2003 Ren Fail pmid:12911161
Patrono C Aspirin resistance: definition, mechanisms and clinical read-outs. 2003 J. Thromb. Haemost. pmid:12911581
Eder K et al. Conjugated linoleic acids lower the release of eicosanoids and nitric oxide from human aortic endothelial cells. 2003 J. Nutr. pmid:14652352
Li JS et al. [Change in intestinal free radical and prostaglandin metabolism in the aged rats with pneumococcus pneumonia]. 2003 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:14552688
Lombard JH et al. High-salt diet impairs vascular relaxation mechanisms in rat middle cerebral arteries. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12456391
De La Cruz JP et al. Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers. 2003 Fundam Clin Pharmacol pmid:12803576
Fujimoto Y et al. Effects of endocrine disruptors on arachidonic acid metabolism in rabbit platelets. 2003 Toxicol. Appl. Pharmacol. pmid:12781627
Cipollone F et al. Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. 2003 Circulation pmid:12515743
Li ZG et al. [Progress on study of experimental physico-chemical indexes related with ischemic stroke]. 2003 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:12764922
Lei D et al. Antioxidative and antiplatelet effects of aqueous inflorescence Piper betle extract. 2003 J. Agric. Food Chem. pmid:12643677
Park WH et al. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity. 2003 Int. Immunopharmacol. pmid:12810354
Hou X et al. Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity. 2003 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:12626359
Tsuruta LR et al. Characterization of 11-dehydro-thromboxane B2 recombinant antibody obtained by phage display technology. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12628223
Nagase T et al. A potent inhibitor of cytosolic phospholipase A2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12505870
Davì G et al. Platelet activation in obese women: role of inflammation and oxidant stress. 2002 Oct 23-30 JAMA pmid:12387653
Hayashi M et al. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. 2002 Nov-Dec Eur. J. Haematol. pmid:12460234
Wolfram RM et al. Effect of black tea on (iso-)prostaglandins and platelet aggregation in healthy volunteers. 2002 May-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:12144875
Alarayyed NA et al. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro. 2002 Aug-Sep Platelets pmid:12189011
Ersöz G et al. Effect of submaximal and incremental upper extremity exercise on platelet function and the role of blood shear stress. 2002 Thromb. Res. pmid:12676189
Connolly E et al. Cyclooxygenase isozyme expression and intimal hyperplasia in a rat model of balloon angioplasty. 2002 J. Pharmacol. Exp. Ther. pmid:11805196
Bermejo BP et al. Sesquiterpenes from Jasonia glutinosa: in vitro anti-inflammatory activity. 2002 Biol. Pharm. Bull. pmid:11824534
Ersöz G et al. The effect of submaximal exercise on platelet aggregation during late follicular and midluteal phases in women. 2002 Thromb. Res. pmid:12590951
Küsters S et al. Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. 2002 Arzneimittelforschung pmid:11878205
Schelzig H et al. Role of recombinant hirudin in a pig-to-human lung transplantation model. 2002 Transplant. Proc. pmid:12270449
Huang CG et al. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. 2002 Thromb. Res. pmid:12297129
Lees P and Landoni MF Pharmacodynamics and enantioselective pharmacokinetics of racemic carprofen in the horse. 2002 J. Vet. Pharmacol. Ther. pmid:12485349
Lassus P et al. Pulmonary prostacyclin is associated with less severe respiratory distress in preterm infants. 2002 Early Hum. Dev. pmid:11893431
Venuto R et al. Enhanced vascular effects of the Ca(2+) channel agonist Bay K 8644 in pregnant rabbits. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11893597
Tang L et al. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue]. 2002 Zhonghua Fu Chan Ke Za Zhi pmid:12487927
Wainwright CL et al. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. 2002 Br. J. Pharmacol. pmid:11959790
Tuersun K and Huang Y [Changes of blood vessel active substances in acute pulmonary embolism induced by echinococus granulous cyst in rabbits]. 2002 Zhonghua Jie He He Hu Xi Za Zhi pmid:12490126
Sheu JR et al. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. 2002 Anesthesiology pmid:11873041
Horiguchi T et al. Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema. 2002 Arzneimittelforschung pmid:12442639
Zaitsu M et al. Induction of thromboxane A2 synthesizing enzymes in DMSO-induced granulocytic differentiation of HL-60 cells. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468261
Thomson M et al. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468270
Sheu JR et al. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. 2002 Br. J. Haematol. pmid:12472585
Fiorucci S et al. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. 2002 Circulation pmid:12473561
Rouvier J et al. Aspirin resistance. 2002 Circulation pmid:12473569
Miyataka M et al. Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2. 2002 Hypertension pmid:11897764
Leahy KM et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. 2002 Cancer Res. pmid:11830509
Ozaki N et al. Differential regulation of prostacyclin and thromboxane by dexamethasone and celecoxib during oxidative stress in newborn rabbits. 2002 Prostaglandins Other Lipid Mediat. pmid:12428679
Ma LP et al. Inhibition of platelet aggregation and expression of alpha granule membrane protein 140 and thromboxane B2 with pravastatin therapy for hypercholesterolemia. 2002 J Assoc Acad Minor Phys pmid:11852667
Ochi T and Goto T Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. 2002 Br. J. Pharmacol. pmid:11834626
De La Cruz JP et al. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction. 2002 Br. J. Pharmacol. pmid:12429581
Bruno A et al. Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. 2002 Stroke pmid:11779889
Canbaz M et al. Effects of tibolone on thromboxane B(2) levels in postmenopausal women. 2002 Gynecol. Obstet. Invest. pmid:11803222
Jeng JH et al. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. 2002 Free Radic. Biol. Med. pmid:11978487
Streppa HK et al. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood. 2002 Am. J. Vet. Res. pmid:16206787
Jiang Z et al. [The changes of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha(6-keto-PGF1 alpha) in the lungs of rats drowned in hypothermic-sea-water]. 2002 Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi pmid:14694611
Saareks V et al. Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. 2002 Pharmacol. Toxicol. pmid:12403056
Kudolo GB et al. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. 2002 Thromb. Res. pmid:12590952
Sinzinger H Comments on "Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications". 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12445490
Obase Y et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. 2002 Chest pmid:11796443
Gordon SM et al. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. 2002 Clin. Pharmacol. Ther. pmid:12189364
Van Hecken A et al. Effects of enteric-coated, low-dose aspirin on parameters of platelet function. 2002 Aliment. Pharmacol. Ther. pmid:12197849
Gómez-Gaviro MV et al. Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. 2002 J. Biol. Chem. pmid:12147693
Khan AA et al. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. 2002 Clin. Pharmacol. Ther. pmid:12152003
Vecino AM et al. Phospholipase A2 activity in platelets of patients with uremia. 2002 Platelets pmid:12487789
Kirchheiner J et al. Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2. 2002 Clin. Pharmacol. Ther. pmid:12152005
Wang L et al. Enhancement of human platelet activation by the combination of low concentrations of collagen and rabbit anticardiolipin antibodies. 2002 Br. J. Haematol. pmid:12199800
Park CH et al. Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors. 2002 Eur J Med Chem pmid:12204472
Cipollone F et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 2002 Circulation pmid:12135935
Association between ibuprofen, aspirin therapy found. 2002 J Am Dent Assoc pmid:12136787
Rinder HM et al. Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial. 2002 J Clin Pharmacol pmid:12162470
Wong DA et al. Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). 2002 J. Exp. Med. pmid:12163563
Kiemer AK et al. Inhibition of cyclooxygenase-2 by natriuretic peptides. 2002 Endocrinology pmid:11861506
Huang K et al. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. 2002 Atherosclerosis pmid:11947907
Hu X et al. [The influence of nasal continual positive airway pressure on some vasoactive substances in patients with obstructive sleep apnea syndrome]. 2002 Zhonghua Jie He He Hu Xi Za Zhi pmid:11953098
Burleigh ME et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. 2002 Circulation pmid:11956125
Jankov RP et al. Thromboxane A(2) receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. 2002 Am. J. Respir. Crit. Care Med. pmid:12119234
Signorello MG et al. Effect of homocysteine on arachidonic acid release in human platelets. 2002 Eur. J. Clin. Invest. pmid:11952814
Leese PT et al. Valdecoxib does not impair platelet function. 2002 Am J Emerg Med pmid:12098171
Tsukamoto H et al. Simultaneous quantification of prostaglandins, isoprostane and thromboxane in cell-cultured medium using gas chromatography-mass spectrometry. 2002 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12076690
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Jung K et al. The effect of dietary intervention through the modification of fatty acids composition and antioxidant vitamin intake on plasma TXB(2) level in Korean postmenopausal women with hypercholesterolemia. 2002 J. Korean Med. Sci. pmid:12068132
Jung YS et al. Antithrombotic effect of onion in streptozotocin-induced diabetic rat. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12054917
van Kraaij DJ et al. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. 2002 Br J Clin Pharmacol pmid:12047490
Appleyard CB et al. Temporal changes in colonic vascular architecture and inflammatory mediator levels in animal models of colitis. 2002 Dig. Dis. Sci. pmid:12353846
Saldeen P et al. Structural, functional and circulatory placental changes associated with impaired glucose metabolism. 2002 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:12381475
Zhang H et al. [Perioperative lung injury in ventricular septal defect with severe pulmonary hypertension, a clinical study of 31 cases]. 2002 Zhonghua Yi Xue Za Zhi pmid:12425808
Jones CJ et al. In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs. 2002 Am. J. Vet. Res. pmid:12428662
Buluç M et al. Effect of misoprostol and indomethacin on cyclooxygenase induction and eicosanoid production in carrageenan-induced air pouch inflammation in rats. 2002 Prostaglandins Other Lipid Mediat. pmid:12428691
Gray PA et al. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. 2002 Br. J. Pharmacol. pmid:12429575
Valeri CR et al. Circulation and hemostatic function of autologous fresh, liquid-preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy. 2002 Transfusion pmid:12430680
Wilner KD et al. Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers. 2002 J Clin Pharmacol pmid:12211219
Molina V et al. D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12213431
Koizumi T et al. Inhibition of endogenous nitric oxide during endotoxemia in awake sheep - effects of Nomega-nitro-l-arginine on the distribution of pulmonary vascular resistance and prostanoid products. 2002 Exp. Lung Res. pmid:12217213
Khan I et al. Altered expression of Na(+)/H(+) exchanger isoforms 1 and 3 in clipped and unclipped kidneys of a 2-kidney-1-clip Goldblatt model of hypertension. 2002 Nephron pmid:12218313
Vaughan JE and Walsh SW Oxidative stress reproduces placental abnormalities of preeclampsia. 2002 Hypertens Pregnancy pmid:12517328
Ferlito M et al. Implication of Galpha i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production. 2002 J. Endotoxin Res. pmid:12701623